Home » Topics » Regulatory

Regulatory
RSS

Baxter obtains marketing approval in Europe for HyQvia

May 22, 2013

FDA approves Xofigo in treatment of CRPC with bone metastases

May 16, 2013

Janssen obtains FDA approval for use of Simponi in new indication

May 16, 2013

FDA approves Breo Ellipta for treatment of COPD

May 13, 2013

Novartis obtains FDA approval for Ilaris in active systemic juvenile idiopathic arthritis

May 13, 2013

Merck & Co. gains FDA approval for Liptruzet combination tablet

May 6, 2013

Hexyon/Hexacima 6-in-1 pediatric vaccine approved in Europe

April 23, 2013

FDA approves beta-blocker-free, fixed-combination therapy for glaucoma

April 23, 2013

Hydrea approved for essential thrombocythemia and polycythemia vera in Japan

April 4, 2013

Neoral receives an additional indication approval in Japan

April 3, 2013

Popular Stories

Today's news in brief
BioWorld
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke
BioWorld Science
Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...
New mechanism of action identified for QC-6352
BioWorld Science
QC-6352 is a small molecule developed to inhibit the histone demethylase 4 (KDM4) that has shown potent antitumoral activity and which has a derivative named...
VST Bio’s VB-001 is neuroprotector after stroke
BioWorld Science
At the recent International Stroke Conference, researchers from VST Bio Corp. and Yale University presented preclinical data regarding VB-001, a monoclonal...